To advance the development of KeraStat® Cream as a treatment of Cutaneous Radiation Injury (CRI).

Award Notice Posted

Solicitation number
75A50122C00017
Agency
Awarded
to Keranetics Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75A50122C00017 Federal contract award
NAICS code
Not on record
PSC
Not on record
Place of performance
Winston Salem, North Carolina 27101, United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response announces a contract awarded to KeraNetics, Inc. on March 17, 2022 for $4,471,066 to advance the development of KeraStat Cream as a medical device countermeasure for the treatment of Cutaneous Radiation Injury pursuant to a Broad Agency Announcement as a cost plus fixed fee contract.

Notice text

Contract to advance the development of KeraStat® Cream as a

medical device type of countermeasure for the treatment of Cutaneous Radiation Injury.  Contract awarded pursuant to Broad Agency Announcement as a cost plus fix fee contract

Awarded contract 75A50122C00017 to KeraNetics, Inc. for 4471066.00 on 2022-03-17.

Notice history

Notice Type Posted
This notice Latest Award Notice
Advance development of KeraStat Cream as a medical device Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors